EV
LHDX

Eclipse Ventures’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Eclipse Ventures’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,223,795
Closed -$1.43M – 3
2023
Q1 		$1.43M Hold
6,223,795
– – 1.16% 3
2022
Q4 		$691K Hold
6,223,795
– – 0.62% 3
2022
Q3 		$6.6M Hold
6,223,795
– – 2.46% 3
2022
Q2 		$11.6M Hold
6,223,795
– – 5.34% 3
2022
Q1 		$22.2M Hold
6,223,795
– – 5.56% 3
2021
Q4 		$53.6M Buy
+6,223,795
New +$39.6M 8.95% 3

Other funds holding LHDX

RA
Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Eclipse Ventures's LHDX Position: Q2 2023 in Review

Eclipse Ventures sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2023, closing a stake of 6,223,795 shares — an estimated $1.43M sold.

Eclipse Ventures first reported a position in LHDX in Q4 2021 and held it in 6 quarters. The position peaked at $53.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds LHDX as of Q2 2023.

  • Eclipse Ventures reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Eclipse Ventures sold 6,223,795 Lucira Health, Inc. Common Stock shares in Q2 2023, an estimated $1.43M.
  • Eclipse Ventures first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Eclipse Ventures's Lucira Health, Inc. Common Stock position peaked at $53.6M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2023.

Based on Eclipse Ventures's 13F filing for Q2 2023, filed 10 Aug 2023.